We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

37 hedge funds and large institutions have $36M invested in BioSpecifics Technologies Corp. in 2013 Q2 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
+37
Holders Change %
–
% of All Funds
1.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
37
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
26
Barclays
United Kingdom
$82K +$85.1K +5,289 New
U
27
UBS
Switzerland
$80K +$82K +5,099 New
AIG
28
American International Group
New York
$53.3K +$54.9K +3,414 New
BIT
29
BlackRock Institutional Trust
California
$46K +$47.2K +2,935 New
NFA
30
Nationwide Fund Advisors
Ohio
$34K +$35.6K +2,211 New
Bank of Montreal
31
Bank of Montreal
Ontario, Canada
$30K +$31.4K +1,949 New
US Bancorp
32
US Bancorp
Minnesota
$29K +$29.5K +1,836 New
TCIM
33
TIAA CREF Investment Management
New York
$7K +$7.43K +462 New
Manulife (Manufacturers Life Insurance)
34
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4K +$4.49K +279 New
TRCT
35
Tower Research Capital (TRC)
New York
$3K +$3.33K +207 New
AllianceBernstein
36
AllianceBernstein
Tennessee
$1K +$1.29K +80 New
RFC
37
Russell Frank Company
Washington
– +$483 +30 New
1
2

BSTC Hedge Fund Activity: Q2 2013 in Review

37 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q2 2013, worth a combined $36M.

Buyers outnumbered sellers: 37 funds opened new BSTC positions and 0 closed out — a net gain of 37 holders — while 0 added to existing stakes and 0 trimmed.

  • 37 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $36M of BioSpecifics Technologies Corp. stock for Q2 2013.
  • 37 funds opened new BioSpecifics Technologies Corp. positions in Q2 2013 and 0 closed out, a net change of +37 holders.

Based on aggregated 13F filings for Q2 2013.